FIRST LINE 5-FU-BASED CHEMOTHERAPY WITH/WITHOUT BEVACIZUMAB FOR METASTATIC COLORECTAL CANCER: TISSUE BIOMARKER CANDIDATES

by Assia Konsoulova, Ivan Donev, Nikolay Conev, Sonya Draganova, Nadezhda Petrova, Eleonora Dimitrova, Hristo Popov, Kameliya Bratoeva, Petar Ghenev
Published 2016-03-01